Brief: Nuvation Bio Q3 EPS USD -0.16
03/11/2025 21:05
Nov 03 (Reuters) - Nuvation Bio Q3 revenue USD 7.723 million vs. IBES estimate USD 6.8 million. Q3 income from pperations USD -56.434 million Q3 operating expenses USD 66.205 million Q3 pretax profit USD -55.792 million Q3 net income USD -55.792 million
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth